Skip to main content

UBS Group AG

Position in CORT — Corcept Therapeutics Inc

CIK 1610520 ZURICH, V8

Position in CORT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$119,787,362
+$64,817,906 QoQ
Shares Held
1,377,658
+1.0% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 423 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in CORT Over Time

Shares Held

Position Value (USD)

Derivatives in CORT

reported options exposure · as of Dec 31, 2025
CallValue
$327,120
CallShares
9,400
PutValue
$70,943,280
PutShares
2,038,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CORT ranks #16 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CORT

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $119,787,362 1,377,658
2026-03-31 $54,969,456 1,363,668
2025-12-31 $327,120 9,400
2025-12-31 $70,943,280 2,038,600
2025-12-31 $14,436,814 414,851
2025-09-30 $45,705,346 549,938
2025-06-30 $7,856,735 107,040
2025-03-31 $42,564,424 372,653
2024-12-31 $12,605,661 250,162
2024-09-30 $8,246,910 178,196
2024-06-30 $5,405,588 166,377
2024-03-31 $4,265,523 169,334
2023-12-31 $4,320,943 133,034
2023-09-30 $1,868,014 68,551
2023-06-30 $1,066,308 47,924
2023-03-31 $745,774 34,431
2022-12-31 $636,210 31,325
2022-09-30 $849,991 33,151
2022-06-30 $764,669 32,156
2022-03-31 $5,472,157 242,991
2021-12-31 $4,743,604 239,576
2021-09-30 $740,203 37,612
2021-06-30 $2,231,504 101,432
2021-03-31 $988,926 41,569
2020-12-31 $1,071,199 40,948
2020-09-30 $731,220 42,000
2020-06-30 $2,225,353 132,304
2020-03-31 $3,776,061 317,583